Cargando…

Health Technology Assessment in Osteoporosis

We review the various aspects of health technology assessment in osteoporosis, including epidemiology and burden of disease, and assessment of the cost-effectiveness of recent advances in the treatment of osteoporosis and the prevention of fracture, in the context of the allocation of health-care re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hiligsmann, Mickael, Kanis, John A., Compston, Juliet, Cooper, Cyrus, Flamion, Bruno, Bergmann, Pierre, Body, Jean-Jacques, Boonen, Steven, Bruyere, Olivier, Devogelaer, Jean-Pierre, Goemaere, Stefan, Kaufman, Jean-Marc, Rozenberg, Serge, Reginster, Jean-Yves
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer New York 2013
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3696176/ https://www.ncbi.nlm.nih.gov/pubmed/23515633 http://dx.doi.org/10.1007/s00223-013-9724-8

Ejemplares similares

Effects of Dairy Products Consumption on Health: Benefits and Beliefs—A Commentary from the Belgian Bone Club and the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases
por: Rozenberg, Serge, et al.
Publicado: (2015)

Extraskeletal benefits and risks of calcium, vitamin D and anti-osteoporosis medications
por: Body, J.-J., et al.
Publicado: (2012)

Non-pharmacological management of osteoporosis: a consensus of the Belgian Bone Club
por: Body, J.-J., et al.
Publicado: (2011)

Evidence-based guidelines for the pharmacological treatment of postmenopausal osteoporosis: a consensus document by the Belgian Bone Club
por: Body, J.-J., et al.
Publicado: (2010)

Loading and Skeletal Development and Maintenance
por: Bergmann, P., et al.
Publicado: (2010)

Prevention and Treatment of Glucocorticoid-Induced Osteoporosis in Adults: Consensus Recommendations From the Belgian Bone Club
por: Laurent, Michaël R., et al.
Publicado: (2022)

Evidence-based guidelines for the use of biochemical markers of bone turnover in the selection and monitoring of bisphosphonate treatment in osteoporosis: a consensus document of the Belgian Bone Club
por: Bergmann, P, et al.
Publicado: (2009)

Patients’ preferences for osteoporosis drug treatment: a discrete-choice experiment
por: Hiligsmann, Mickaël, et al.
Publicado: (2014)

Adverse Reactions and Drug–Drug Interactions in the Management of Women with Postmenopausal Osteoporosis
por: Rizzoli, René, et al.
Publicado: (2011)

Osteoporosis in Frail Patients: A Consensus Paper of the Belgian Bone Club
por: Gielen, E., et al.
Publicado: (2017)

Experts’ preferences for sarcopenia outcomes: a discrete-choice experiment from a working group of the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) in collaboration with the European Union of Geriatric Medicine Society (EUGMS)
por: Beaudart, Charlotte, et al.
Publicado: (2021)

The Value of a Patient-Level Modeling Approach and Need for Better Reporting in Economic Evaluations of Osteoporosis
por: Hiligsmann, Mickael, et al.
Publicado: (2020)

Unmet needs and current and future approaches for osteoporotic patients at high risk of hip fracture
por: Ferrari, Serge, et al.
Publicado: (2016)

Publication outcomes of the abstracts presented at the 2011 European Congress on Osteoporosis, Osteoarthritis and Musculo-Skeletal Diseases (ECCEO-IOF11): A position paper of the European Society for Clinical and Economical Aspects of Osteoporosis, Osteoarthritis and Musculo-Skeletal Diseases (ESCEO) and the International Osteoporosis and Other Skeletal Diseases Foundation (IOF)
por: Rabenda, Véronique, et al.
Publicado: (2015)

Novel formulations of oral bisphosphonates in the treatment of osteoporosis
por: Fuggle, Nicholas, et al.
Publicado: (2022)

Vitamin D supplementation in the prevention and management of major chronic diseases not related to mineral homeostasis in adults: research for evidence and a scientific statement from the European society for clinical and economic aspects of osteoporosis and osteoarthritis (ESCEO)
por: Cianferotti, Luisella, et al.
Publicado: (2017)

Correction: Novel formulations of oral bisphosphonates in the treatment of osteoporosis
por: Fuggle, Nicholas, et al.
Publicado: (2023)

Osteoporosis and sarcopenia: two diseases or one?
por: Reginster, Jean-Yves, et al.
Publicado: (2016)

Nominal group technique to select attributes for discrete choice experiments: an example for drug treatment choice in osteoporosis
por: Hiligsmann, Mickael, et al.
Publicado: (2013)

Inappropriate claims from non-equivalent medications in osteoarthritis: a position paper endorsed by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO)
por: Bruyère, Olivier, et al.
Publicado: (2017)

Evaluation of symptomatic slow-acting drugs in osteoarthritis using the GRADE system
por: Bruyère, Olivier, et al.
Publicado: (2008)

Efficacy of osteoporosis pharmacological treatments in men: a systematic review and meta-analysis
por: Beaudart, Charlotte, et al.
Publicado: (2023)

Public health impact and cost-effectiveness of dairy products supplemented with vitamin D in prevention of osteoporotic fractures
por: Ethgen, Olivier, et al.
Publicado: (2015)

Can We Identify Patients with High Risk of Osteoarthritis Progression Who Will Respond to Treatment? A Focus on Epidemiology and Phenotype of Osteoarthritis
por: Bruyère, Olivier, et al.
Publicado: (2015)

A reappraisal of generic bisphosphonates in osteoporosis
por: Kanis, J. A., et al.
Publicado: (2011)

Intervention thresholds and diagnostic thresholds in the management of osteoporosis
por: Kanis, John A., et al.
Publicado: (2022)

Diacerein: Benefits, Risks and Place in the Management of Osteoarthritis. An Opinion-Based Report from the ESCEO
por: Pavelka, Karel, et al.
Publicado: (2016)

Maintenance of antifracture efficacy over 10 years with strontium ranelate in postmenopausal osteoporosis
por: Reginster, J-Y., et al.
Publicado: (2011)

An Updated Systematic Review of Cost-Effectiveness Analyses of Drugs for Osteoporosis
por: Li, Nannan, et al.
Publicado: (2020)

Cost-effectiveness of strontium ranelate in the treatment of male osteoporosis
por: Hiligsmann, M., et al.
Publicado: (2013)

Importance of Safety in the Management of Osteoarthritis and the Need for Updated Meta-Analyses and Recommendations for Reporting of Harms
por: Reginster, Jean-Yves, et al.
Publicado: (2019)

A Review of Patient Preferences for Osteoporosis Drug Treatment
por: Hiligsmann, Mickaël, et al.
Publicado: (2015)

Algorithm for the Use of Biochemical Markers of Bone Turnover in the Diagnosis, Assessment and Follow-Up of Treatment for Osteoporosis
por: Lorentzon, Mattias, et al.
Publicado: (2019)

Cost Effectiveness Analyses of Interventions for Osteoporosis in Men: A Systematic Literature Review
por: Li, Nannan, et al.
Publicado: (2023)

A scoping review of the public health impact of vitamin D-fortified dairy products for fracture prevention
por: Hiligsmann, Mickael, et al.
Publicado: (2017)

Correction to: Cost Effectiveness Analyses of Interventions for Osteoporosis in Men: A Systematic Literature Review
por: Li, Nannan, et al.
Publicado: (2023)

Vitamin D and osteosarcopenia: an update from epidemiological studies
por: Bruyère, Olivier, et al.
Publicado: (2017)

Update on the role of pharmaceutical-grade chondroitin sulfate in the symptomatic management of knee osteoarthritis
por: Honvo, Germain, et al.
Publicado: (2019)

Health Economic Evaluation of a High and Low Molecular Weight Hyaluronic Acid Formulation for the Treatment of Knee Osteoarthritis. Post Hoc Analyses from a Randomized Clinical Trial
por: Bruyère, Olivier, et al.
Publicado: (2022)

Health Technology Assessment of Different Glucosamine Formulations and Preparations Currently Marketed in Thailand
por: Bruyère, Olivier, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_mkchbcmp7ujumvu7cc8at5mbcc